The Rise of Targeted Therapies

Cancer treatment has historically relied on broad-spectrum approaches like chemotherapy and radiation, impacting healthy cells alongside cancerous ones. This often leads to debilitating side effects. Biotech companies, however, are spearheading a revolution with targeted therapies. These treatments focus specifically on cancerous cells, exploiting their unique characteristics, such as genetic mutations or overexpressed proteins. This precision approach minimizes harm to healthy tissue, improving patient outcomes and quality of life. Examples include monoclonal antibodies that target specific proteins on cancer cells, or small molecule inhibitors that block the activity of cancer-driving enzymes. This level of specificity is